Literature DB >> 28002866

Botulinum Toxin Injections in Musculoskeletal Disorders.

Ivan R B Godoy1, Dean M Donahue2, Martin Torriani1.   

Abstract

Botulinum toxin (BTX) is used for multiple clinical indications due to its ability to induce temporary chemodenervation and muscle paralysis. This property has supported its application in treating a variety of musculoskeletal conditions, especially those involving muscular hyperactivity and contractures such as cerebral palsy and dystonia. However, off-label use of BTX injection in other musculoskeletal disorders is gaining increased acceptance, such as in neurogenic thoracic outlet syndrome, epicondylitis, and shoulder pain after stroke. This review discusses the mechanism of action, best practices, and current indications of BTX injections in the musculoskeletal system. We also discuss the state of the science regarding BTX injections for musculoskeletal disorders and the available evidence supporting its use. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28002866     DOI: 10.1055/s-0036-1594284

Source DB:  PubMed          Journal:  Semin Musculoskelet Radiol        ISSN: 1089-7860            Impact factor:   1.777


  2 in total

1.  Current updates in image-guided musculoskeletal interventions.

Authors:  Abhinav Bansal; Ankur Goyal; Shivanand Gamanagatti; Deep Narayan Srivastava; Vikrant Manhas
Journal:  J Clin Orthop Trauma       Date:  2021-09-16

Review 2.  The Use of Botulinum Toxin A as an Adjunctive Therapy in the Management of Chronic Musculoskeletal Pain: A Systematic Review with Meta-Analysis.

Authors:  Simone Battista; Luca Buzzatti; Marialuisa Gandolfi; Cinzia Finocchi; Luca Falsiroli Maistrello; Antonello Viceconti; Benedetto Giardulli; Marco Testa
Journal:  Toxins (Basel)       Date:  2021-09-10       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.